Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies

Patients with lymphoproliferative diseases are at an increased risk of an incomplete immune response following vaccination or SARS‐CoV‐2 infection and might develop persistent viral infection and severe COVID‐19 disease. We present a case of successful treatment of persistent and mechanical‐ventilat...

Descripción completa

Detalles Bibliográficos
Autores principales: Seganfredo, Fernanda Braga, Dias, Ana Raquel, Santos, Pedro R., Rebelo, Marta, João, Cristina, Mendes, Dina, Carmo, Eduarda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666912/
https://www.ncbi.nlm.nih.gov/pubmed/36408087
http://dx.doi.org/10.1002/ccr3.6548
_version_ 1784831608033902592
author Seganfredo, Fernanda Braga
Dias, Ana Raquel
Santos, Pedro R.
Rebelo, Marta
João, Cristina
Mendes, Dina
Carmo, Eduarda
author_facet Seganfredo, Fernanda Braga
Dias, Ana Raquel
Santos, Pedro R.
Rebelo, Marta
João, Cristina
Mendes, Dina
Carmo, Eduarda
author_sort Seganfredo, Fernanda Braga
collection PubMed
description Patients with lymphoproliferative diseases are at an increased risk of an incomplete immune response following vaccination or SARS‐CoV‐2 infection and might develop persistent viral infection and severe COVID‐19 disease. We present a case of successful treatment of persistent and mechanical‐ventilation‐requiring SARS‐CoV‐2 infection in a del17(+) CLL patient using exogenous antibodies.
format Online
Article
Text
id pubmed-9666912
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96669122022-11-17 Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies Seganfredo, Fernanda Braga Dias, Ana Raquel Santos, Pedro R. Rebelo, Marta João, Cristina Mendes, Dina Carmo, Eduarda Clin Case Rep Case Report Patients with lymphoproliferative diseases are at an increased risk of an incomplete immune response following vaccination or SARS‐CoV‐2 infection and might develop persistent viral infection and severe COVID‐19 disease. We present a case of successful treatment of persistent and mechanical‐ventilation‐requiring SARS‐CoV‐2 infection in a del17(+) CLL patient using exogenous antibodies. John Wiley and Sons Inc. 2022-11-15 /pmc/articles/PMC9666912/ /pubmed/36408087 http://dx.doi.org/10.1002/ccr3.6548 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Seganfredo, Fernanda Braga
Dias, Ana Raquel
Santos, Pedro R.
Rebelo, Marta
João, Cristina
Mendes, Dina
Carmo, Eduarda
Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies
title Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies
title_full Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies
title_fullStr Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies
title_full_unstemmed Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies
title_short Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies
title_sort successful treatment of persistent and severe sars‐cov‐2 infection in a high‐risk chronic lymphocytic leukemia patient using ronapreve™ antibodies
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666912/
https://www.ncbi.nlm.nih.gov/pubmed/36408087
http://dx.doi.org/10.1002/ccr3.6548
work_keys_str_mv AT seganfredofernandabraga successfultreatmentofpersistentandseveresarscov2infectioninahighriskchroniclymphocyticleukemiapatientusingronapreveantibodies
AT diasanaraquel successfultreatmentofpersistentandseveresarscov2infectioninahighriskchroniclymphocyticleukemiapatientusingronapreveantibodies
AT santospedror successfultreatmentofpersistentandseveresarscov2infectioninahighriskchroniclymphocyticleukemiapatientusingronapreveantibodies
AT rebelomarta successfultreatmentofpersistentandseveresarscov2infectioninahighriskchroniclymphocyticleukemiapatientusingronapreveantibodies
AT joaocristina successfultreatmentofpersistentandseveresarscov2infectioninahighriskchroniclymphocyticleukemiapatientusingronapreveantibodies
AT mendesdina successfultreatmentofpersistentandseveresarscov2infectioninahighriskchroniclymphocyticleukemiapatientusingronapreveantibodies
AT carmoeduarda successfultreatmentofpersistentandseveresarscov2infectioninahighriskchroniclymphocyticleukemiapatientusingronapreveantibodies

Ejemplares similares